BIOLASE Stock (NASDAQ:BIOL)


Chart

Previous Close

$0.02

52W Range

$0.02 - $1.94

50D Avg

$0.06

200D Avg

$0.28

Market Cap

$731.94K

Avg Vol (3M)

$201.37K

Beta

0.68

Div Yield

-

BIOL Company Profile


BIOLASE, Inc., together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, such as cosmetic, restorative, and complex surgical applications. The company offers Waterlase all-tissue dental laser systems for cutting soft and hard tissues; diode soft-tissue laser systems for soft tissue, pain therapy, teeth whitening, and cosmetic procedures; and Epic Hygiene laser to manage non-surgical periodontitis and enhance clinical production. It also manufactures and sells consumable products and accessories for its laser systems, as well as markets flexible fibers and hand pieces, and teeth whitening gel kits. The company sells its products through its field sales force and distributor network. The company was formerly known as BIOLASE Technology, Inc. and changed its name to BIOLASE, Inc. in 2012. BIOLASE, Inc. was founded in 1984 and is headquartered in Foothill Ranch, California.

Show More

Industry

Medical - Devices

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

157

IPO Date

Nov 12, 1992

Website

BIOL Performance


Latest Earnings Call Transcripts


Q2 22Aug 11, 22 | 10:25 PM
Q1 22May 12, 22 | 10:14 PM
Q4 21Mar 17, 22 | 6:44 PM

Peer Comparison


TickerCompany
TNDMTandem Diabetes Care, Inc.
DXCMDexCom, Inc.
PACBPacific Biosciences of California, Inc.
NAOVNanoVibronix, Inc.